RE: Hemo sp in six months8 Jul 2020 20:20
I still haven’t found anything to point to GlobalCo having to identify themselves by the end of the agreement (Whatever date that is). The below indicates that they get to the end of the agreement Period and then decide what happens next. I would imagine that once they have decided which route to take, GlobalCo will then allow themselves to be identified. That will be August earliest IMO.
+++++++++
The collaboration agreement, originally scheduled to complete in late April 2020, is being extended by a short period due to the impact on GlobalCo's operations of the novel coronavirus, following which Hemogenyx will either license the antibody to GlobalCo or will in-license GlobalCo's improvements to it on favourable terms